Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C34H50N4O2.2Cl |
| Molecular Weight | 617.692 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Cl-].CC[N+](CC)(CCCNC1=CC(=O)C(NCCC[N+](CC)(CC)CC2=CC=CC=C2)=CC1=O)CC3=CC=CC=C3
InChI
InChIKey=WQRJZLXQCYZJEU-UHFFFAOYSA-N
InChI=1S/C34H48N4O2.2ClH/c1-5-37(6-2,27-29-17-11-9-12-18-29)23-15-21-35-31-25-34(40)32(26-33(31)39)36-22-16-24-38(7-3,8-4)28-30-19-13-10-14-20-30;;/h9-14,17-20,25-26H,5-8,15-16,21-24,27-28H2,1-4H3;2*1H
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
12 mg single, intravenous Highest studied dose Dose: 12 mg Route: intravenous Route: single Dose: 12 mg Sources: |
unhealthy n = 1 Health Status: unhealthy Condition: anzesthesia Population Size: 1 Sources: |
Other AEs: Colic, Salivation... Other AEs: Colic (1 patient) Sources: Salivation (1 patient) Paresis (1 patient) |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Colic | 1 patient | 12 mg single, intravenous Highest studied dose Dose: 12 mg Route: intravenous Route: single Dose: 12 mg Sources: |
unhealthy n = 1 Health Status: unhealthy Condition: anzesthesia Population Size: 1 Sources: |
| Paresis | 1 patient | 12 mg single, intravenous Highest studied dose Dose: 12 mg Route: intravenous Route: single Dose: 12 mg Sources: |
unhealthy n = 1 Health Status: unhealthy Condition: anzesthesia Population Size: 1 Sources: |
| Salivation | 1 patient | 12 mg single, intravenous Highest studied dose Dose: 12 mg Route: intravenous Route: single Dose: 12 mg Sources: |
unhealthy n = 1 Health Status: unhealthy Condition: anzesthesia Population Size: 1 Sources: |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C66886
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
m71
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
CHEMBL1358790
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
66373
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
311-09-1
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
O6HVT48T15
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
9393
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
C76787
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY | |||
|
DTXSID401026554
Created by
admin on Fri Dec 15 15:05:28 GMT 2023 , Edited by admin on Fri Dec 15 15:05:28 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
